Market Research Industry Today

Whole Clinical Oncology Next Generation Sequencing (NGS) Market Size, Share, Development by 2025 - QY Research, Inc.

This report focuses on the global Clinical Oncology Next Generation Sequencing (NGS) status, future forecast, growth opportunity, key market and key players.
Published 23 August 2018

QYRlogo

This report focuses on the global Clinical Oncology Next Generation Sequencing (NGS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Oncology Next Generation Sequencing (NGS) development in United States, Europe and China.

NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.

The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.

The key players covered in this study

    Illumina

    Roche

    Agilent Technologies

    Knome

    Genomatix Software

    GATC Biotech

    Oxford Nanopore Technologies

    Macrogen

    Life Technologies

    DNASTAR

    Exosome Diagnostics

    Biomatters

    CLC Bio

    BGI

    Qiagen

    Perkin Elmer

    Pacific Bioscience

    Partek

    GnuBIO

    Foundation Medicine

    Paradigm

    Caris Life Sciences

    Myriad Genetics

Market segment by Type, the product can be split into

    NGS Pre-Sequencing

    Sequencing

    NGS Data Analysis

    Primary, Secondary & Tertiary Data Analysis

Market segment by Application, split into

    Academic & Clinical Research

    Hospitals & Clinics

    Pharma & Biotech Entities

Market segment by Regions/Countries, this report covers

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

    Central & South America

The study objectives of this report are:

    To analyze global Clinical Oncology Next Generation Sequencing (NGS) status, future forecast, growth opportunity, key market and key players.

    To present the Clinical Oncology Next Generation Sequencing (NGS) development in United States, Europe and China.

    To strategically profile the key players and comprehensively analyze their development plan and strategies.

    To define, describe and forecast the market by product type, market and key regions.

Request Sample Report and TOC@ http://www.qyresearchglobal.com/goods-1793235.html

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

QY Research Achievements:  

Year of Experience: 11 Years

Consulting Projects: 500+ successfully conducted so far

Global Reports: 5000 Reports Every Years

Resellers Partners for Our Reports: 150 + Across Globe

Global Clients: 34000+

Contact US

QY Research, INC.

Tina

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 295 2442

Email: sales@qyrsearchglobal.com 

Web: www.qyresearchglobal.com

For other region, contact number given below

+86 108 294 5717 Beijing

+852 3062 8839 HK

Other Industry News

Ready to start publishing

Sign Up today!